Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,013 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Chromogranin A as Blood Marker in Cancer Patients

NCT03817866

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +25 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Charité - Universitätsmedizin Berlin Berlin, Germany
View Trial Details
Completed

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

NCT01177397

Conditions
Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +47 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Neuro-Oncology Program Los Angeles, California, United States
  • University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 16 locations
View Trial Details
Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details

Related conditions